loading
Schlusskurs vom Vortag:
$14.82
Offen:
$14.82
24-Stunden-Volumen:
2.09M
Relative Volume:
1.27
Marktkapitalisierung:
$1.28B
Einnahmen:
$-249.00K
Nettoeinkommen (Verlust:
$-187.60M
KGV:
-5.724
EPS:
-2.5
Netto-Cashflow:
$-201.88M
1W Leistung:
-5.67%
1M Leistung:
+6.16%
6M Leistung:
+182.81%
1J Leistung:
+188.51%
1-Tages-Spanne:
Value
$13.88
$15.07
1-Wochen-Bereich:
Value
$13.88
$16.96
52-Wochen-Spanne:
Value
$2.865
$16.96

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Name
Firmenname
Amylyx Pharmaceuticals Inc
Name
Telefon
617-683-0917
Name
Adresse
43 THORNDIKE STREET, CAMBRIDGE
Name
Mitarbeiter
123
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
AMLX's Discussions on Twitter

Vergleichen Sie AMLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AMLX
Amylyx Pharmaceuticals Inc
14.31 1.63B -249.00K -187.60M -201.88M -2.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Fortgesetzt Goldman Buy
2025-06-24 Eingeleitet Guggenheim Buy
2025-06-17 Eingeleitet Citigroup Buy
2025-05-30 Eingeleitet TD Cowen Buy
2025-04-07 Hochstufung Mizuho Neutral → Outperform
2024-11-18 Hochstufung Robert W. Baird Neutral → Outperform
2024-10-23 Hochstufung BofA Securities Neutral → Buy
2024-03-18 Herabstufung Mizuho Buy → Neutral
2024-03-11 Herabstufung Leerink Partners Outperform → Market Perform
2024-03-11 Herabstufung Robert W. Baird Outperform → Neutral
2024-03-08 Herabstufung Evercore ISI Outperform → In-line
2024-03-08 Herabstufung Goldman Buy → Neutral
2024-01-03 Eingeleitet Robert W. Baird Outperform
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-07-24 Hochstufung Goldman Neutral → Buy
2023-03-31 Eingeleitet Mizuho Buy
2023-01-05 Eingeleitet BofA Securities Buy
2022-05-25 Eingeleitet Citigroup Buy
2022-04-01 Herabstufung Goldman Buy → Neutral
Alle ansehen

Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten

pulisher
02:58 AM

Trend analysis for Amylyx Pharmaceuticals Inc. this weekJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com

02:58 AM
pulisher
Oct 23, 2025

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); ... - Bluefield Daily Telegraph

Oct 23, 2025
pulisher
Oct 23, 2025

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - Eastern Progress

Oct 23, 2025
pulisher
Oct 23, 2025

Using flow based indicators on Amylyx Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.July 2025 Setups & Expert Curated Trade Setups - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Will Amylyx Pharmaceuticals Inc. price bounce be sustainableTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Amylyx gets FDA fast track status for ALS treatment - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. t - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Measuring Amylyx Pharmaceuticals Inc.’s beta against major indices2025 Price Targets & Technical Pattern Based Buy Signals - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Will Amylyx Pharmaceuticals Inc. continue its uptrendTrade Exit Summary & Technical Pattern Based Buy Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Tools to monitor Amylyx Pharmaceuticals Inc. recovery probabilityJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Using economic indicators to assess Amylyx Pharmaceuticals Inc. potential2025 Volume Leaders & Daily Price Action Insights - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 22:38:43 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

How the Class Action Investigation Into Relyvrio Disclosures at Amylyx Pharmaceuticals (AMLX) Has Changed Its Investment Story - Sahm

Oct 19, 2025
pulisher
Oct 19, 2025

How Amylyx Pharmaceuticals Inc. stock benefits from global expansionRecession Risk & Advanced Technical Signal Analysis - nchmf.gov.vn

Oct 19, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

How supply chain issues affect Amylyx Pharmaceuticals Inc. stockPortfolio Return Report & Scalable Portfolio Growth Methods - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Growth Value: Why Amylyx Pharmaceuticals Inc. stock attracts global investorsBull Run & High Yield Equity Trading Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonInsider Buying & Expert Approved Momentum Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Aug Swings: Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Summary & Low Risk Profit Maximizing Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Volatility Watch: Will Amylyx Pharmaceuticals Inc. stock beat EPS estimates2025 Technical Overview & Free Real-Time Market Sentiment Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Amylyx Pharmaceuticals (AMLX): Assessing Valuation After Class Action Probe Challenges Relyvrio Demand Claims - Sahm

Oct 17, 2025
pulisher
Oct 17, 2025

Will Amylyx Pharmaceuticals Inc. stock beat EPS estimatesShort Setup & Weekly Top Performers Watchlists - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Exit Recap: Is Amylyx Pharmaceuticals Inc. stock affected by interest rate hikesGold Moves & Expert Curated Trade Setups - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Oklahoma City NewsThe Oklahoman - FinancialContent

Oct 17, 2025
pulisher
Oct 17, 2025

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Assessing the 15.36% Upside Potential and Strong Analyst Ratings - DirectorsTalk Interviews

Oct 17, 2025
pulisher
Oct 16, 2025

Is AMLX Stock a Solid Choice Right Now? - sharewise.com

Oct 16, 2025
pulisher
Oct 16, 2025

AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire

Oct 16, 2025
pulisher
Oct 16, 2025

About Us - FinancialContent

Oct 16, 2025
pulisher
Oct 16, 2025

Baird Maintains Amylyx Pharmaceuticals (AMLX) Outperform Recommendation - Nasdaq

Oct 16, 2025
pulisher
Oct 15, 2025

How institutional ownership impacts Amylyx Pharmaceuticals Inc. stockWeekly Trend Recap & Technical Pattern Based Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Amylyx Pharmaceuticals prices $175M public offering - MSN

Oct 14, 2025

Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.85
price up icon 0.03%
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
Kapitalisierung:     |  Volumen (24h):